General Purpose
Terminated 5/21/2015
ID: 1307363
·
First filed: May 28, 2008
Baybio Pac, Sponsored By the Bay Area Bioscience Association
View
Receipt Summary
| Source Type | Distribution | Amount | Percentage |
|---|---|---|---|
| Other | $200K | 89.6% | |
| Individual | $19.8K | 8.8% | |
| Committee | $3.53K | 1.6% | |
| Total | $223K | 100% |
Receipts
| Donor | Total Amount | % of Total | |
|---|---|---|---|
|
Bay Area Bioscience Association
Other
|
17.5% | ||
|
Genentech
Other
|
8.1% | ||
|
Gilead Sciences via Baybio
Other
|
6.0% | ||
|
Genentech Inc.
Other
|
3.0% | ||
|
Johnson & Johnson
Other
|
3.0% | ||
|
Genentech Inc. Via Baybio
Other
|
2.9% | ||
|
Gilead Sciences (Via Baybio Assn.)
Other
|
2.9% | ||
|
Amgen Usa
Other
|
2.7% | ||
|
Entelos, Inc.
Other
|
2.7% | ||
|
Pfizer Inc.
Other
|
2.7% | ||
|
Pfizer, Inc.
Other
|
2.7% | ||
|
Alan C. Mendelson
Attorney at Latham & Wakins
|
1.8% | ||
|
Amgen Inc. State Political Contribs Acct.
Other
|
1.3% | ||
|
Celgene Corporation PAC
Committee
|
1.3% | ||
|
Celgene Corp. Via Baybio
Other
|
1.3% | ||
|
Pfizer Inc. (Via Baybio)
Other
|
1.3% | ||
|
Astrazeneca Pharm. (Via Baybio)
Other
|
1.3% | ||
|
Gilead Sciences, Inc.
Other
|
1.3% | ||
|
Xoma
Other
|
1.2% | ||
|
Biomarin
Other
|
1.1% | ||
|
Genentech Inc. (Via Baybio Assn.)
Other
|
1.1% | ||
|
Onyx Pharmaceuticals
Other
|
1.1% | ||
|
Onyx Pharmaceuticals via Baybio
Other
|
1.1% | ||
|
Biomarin Pharmaceutical via Baybio
Other
|
1.1% | ||
|
Abd Insurance and Financial via Baybio
Other
|
1.1% |